Point72 Asset Management Lp decreased Horizon Pharma Plc (Call) (HZNP) stake by 86.31% reported in 2017Q3 SEC filing. Point72 Asset Management Lp sold 3.15 million shares as Horizon Pharma Plc (Call) (HZNP)’s stock declined 38.11%. The Point72 Asset Management Lp holds 500,000 shares with $6.34 million value, down from 3.65 million last quarter. Horizon Pharma Plc (Call) now has $2.39B valuation. The stock decreased 2.28% or $0.34 during the last trading session, reaching $14.6. About 1.25M shares traded. Horizon Pharma Public Limited Company (NASDAQ:HZNP) has declined 28.13% since December 30, 2016 and is downtrending. It has underperformed by 44.83% the S&P500.
Edge Wealth Management Llc increased Bp Plc (BP) stake by 40.36% reported in 2017Q3 SEC filing. Edge Wealth Management Llc acquired 90,622 shares as Bp Plc (BP)’s stock rose 10.53%. The Edge Wealth Management Llc holds 315,151 shares with $12.11 million value, up from 224,529 last quarter. Bp Plc now has $134.57B valuation. The stock increased 0.38% or $0.16 during the last trading session, reaching $42.03. About 3.39M shares traded. BP p.l.c. (NYSE:BP) has risen 15.51% since December 30, 2016 and is uptrending. It has underperformed by 1.19% the S&P500.
Point72 Asset Management Lp increased Sangamo Therapeutics Inc (NASDAQ:SGMO) stake by 335,595 shares to 693,300 valued at $10.40 million in 2017Q3. It also upped Arris Intl Inc stake by 43,435 shares and now owns 325,250 shares. Pra Health Sciences Inc was raised too.
Among 13 analysts covering Horizon Pharma (NASDAQ:HZNP), 10 have Buy rating, 0 Sell and 3 Hold. Therefore 77% are positive. Horizon Pharma had 53 analyst reports since September 9, 2015 according to SRatingsIntel. Cantor Fitzgerald maintained Horizon Pharma Public Limited Company (NASDAQ:HZNP) on Monday, November 6 with “Buy” rating. As per Friday, December 9, the company rating was downgraded by Mizuho. The stock has “Buy” rating by Cowen & Co on Thursday, July 13. On Monday, December 14 the stock rating was maintained by Mizuho with “Buy”. BMO Capital Markets initiated Horizon Pharma Public Limited Company (NASDAQ:HZNP) on Wednesday, June 29 with “Outperform” rating. The stock of Horizon Pharma Public Limited Company (NASDAQ:HZNP) earned “Neutral” rating by Mizuho on Tuesday, May 9. The rating was maintained by BMO Capital Markets with “Buy” on Tuesday, September 26. The company was maintained on Tuesday, August 8 by UBS. The stock has “Buy” rating by Mizuho on Tuesday, February 28. The stock has “Buy” rating by Jefferies on Tuesday, January 19.
Investors sentiment increased to 1 in 2017 Q3. Its up 0.08, from 0.92 in 2017Q2. It improved, as 33 investors sold HZNP shares while 50 reduced holdings. 28 funds opened positions while 55 raised stakes. 132.29 million shares or 1.03% more from 130.94 million shares in 2017Q2 were reported. Royal National Bank Of Canada holds 13,233 shares or 0% of its portfolio. Armistice Capital Ltd Liability Corporation owns 800,000 shares for 1.19% of their portfolio. 83,885 are held by Us Commercial Bank De. Balyasny Asset Mngmt Ltd Limited Liability Company invested in 0% or 92,200 shares. 101,900 were reported by Canada Pension Plan Invest Board. Swiss Financial Bank reported 0% in Horizon Pharma Public Limited Company (NASDAQ:HZNP). Barrett Asset Limited Liability Corp holds 0% or 4,900 shares in its portfolio. 1,000 are held by Pnc Financial Service Gp. Hutchin Hill Capital Lp accumulated 41,100 shares. Credit Suisse Ag has invested 0% in Horizon Pharma Public Limited Company (NASDAQ:HZNP). Chicago Equity Lc holds 0.05% of its portfolio in Horizon Pharma Public Limited Company (NASDAQ:HZNP) for 136,120 shares. Bank & Trust Of Montreal Can, a Ontario – Canada-based fund reported 2,241 shares. Aqr Cap Mngmt Ltd Liability Co, a Connecticut-based fund reported 103,090 shares. State Street holds 4.51M shares. 28,442 were accumulated by Pub Employees Retirement Association Of Colorado.
Analysts await Horizon Pharma Public Limited Company (NASDAQ:HZNP) to report earnings on February, 26. They expect $0.22 earnings per share, down 56.00% or $0.28 from last year’s $0.5 per share. HZNP’s profit will be $36.06 million for 16.59 P/E if the $0.22 EPS becomes a reality. After $0.26 actual earnings per share reported by Horizon Pharma Public Limited Company for the previous quarter, Wall Street now forecasts -15.38% negative EPS growth.
The post Edge Wealth Management Has Lifted Bp Plc (BP) Position; Point72 Asset Management LP Decreased Horizon Pharma Plc (Call) (HZNP) Position By $37.84 Million appeared first on Stock Market News | HillCountryTimes | Get it Today.
from
https://www.hillcountrytimes.com/2017/12/30/edge-wealth-management-has-lifted-bp-plc-bp-position-point72-asset-management-lp-decreased-horizon-pharma-plc-call-hznp-position-by-37-84-million/
No comments:
Post a Comment